Edition:
United States

Stentys SA (STEN.PA)

STEN.PA on Paris Stock Exchange

2.61EUR
20 Jan 2017
Change (% chg)

€-0.04 (-1.51%)
Prev Close
€2.65
Open
€2.61
Day's High
€2.65
Day's Low
€2.61
Volume
12,439
Avg. Vol
57,943
52-wk High
€4.15
52-wk Low
€1.91

STEN.PA

Chart for STEN.PA

About

Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's... (more)

Overall

Beta: 1.00
Market Cap(Mil.): €46.65
Shares Outstanding(Mil.): 17.87
Dividend: --
Yield (%): --

Financials

  STEN.PA Industry Sector
P/E (TTM): -- 33.72 30.38
EPS (TTM): -0.58 -- --
ROI: -38.58 13.18 14.86
ROE: -42.68 16.79 16.28

BRIEF-Stentys 2016 annual revenues up 20 pct at 7.3 million euros

* 2016 annual revenues up 20 pct at 7.3 million euros ($7.78 million)

Jan 12 2017

BRIEF-Stentys Q3 revenue rises to 1.7 million euros

* Q3 revenue 1.7 million euros ($1.90 million) versus 1.6 million year ago

Oct 12 2016

BRIEF-Stentys H1 operating loss narrows to 4.0 million euros

* Reported on Thursday an H1 operating loss of 4.0 million euros ($4.49 million) versus a loss of 5.4 million euros a year ago

Sep 16 2016

Earnings vs. Estimates